Cargando…
Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma
BACKGROUND: Nasopharyngeal carcinoma (NPC) is one of the most common human head and neck cancers with high incidence in Southern China, Southeast Asia and North Africa. Because of its nonspecific symptoms, the early diagnosis of NPC is very difficult. The 5-year survival rate is not ideal in spite o...
Autores principales: | Guo, Yuanwei, Luo, Weihao, Hu, Zheng, Li, Jia, Li, Xiaojie, Cao, Huiqiu, Li, Jun, Wen, Bo, Zhang, Jian, Cheng, Hao, Guo, Wangyuan, Tan, Tan, Luo, Dixian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779195/ https://www.ncbi.nlm.nih.gov/pubmed/26949513 http://dx.doi.org/10.1186/s13578-016-0082-x |
Ejemplares similares
-
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
por: Huang, Li, et al.
Publicado: (2016) -
Aldo-Keto Reductases in the Eye
por: Huang, Shun Ping, et al.
Publicado: (2010) -
Regulation of Aldo–Keto Reductases in Human Diseases
por: Chen, Wei-Dong, et al.
Publicado: (2012) -
Diagnostic value of aldo‑keto reductase family 1 member B10 in human nasopharyngeal carcinoma
por: Lu, Jinping, et al.
Publicado: (2023) -
Aldo-keto reductase (AKR) superfamily: Genomics and annotation
por: Mindnich, Rebekka D, et al.
Publicado: (2009)